| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Sept 2021 |  Dividend | ₹ 0.10 /share | 09 Sept 2021 | 189.20 | 197.80 |
| 25 Aug 2022 | Dividend | ₹ 0.10 /share | 24 Aug 2022 | 243.75 | 205.20 |
| 21 Sept 2023 | Dividend | ₹ 0.10 /share | 21 Sept 2023 | 207.55 | 285.35 |
| 29 Sept 2023 |  Annual General Meeting | NA | 29 Sept 2023 | 308.70 | 286.75 |
| 19 Sept 2024 | Dividend | ₹ 0.10 /share | 17 Sept 2024 | 312.15 | 397.60 |
| 25 Sept 2024 | Annual General Meeting | NA | 25 Sept 2024 | 393.65 | 389.90 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 473.55 | 437.50 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 426.15 | 406.00 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 380.45 | 390.90 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 364.00 | 354.10 |
| 22 Sept 2025 | Dividend | ₹ 0.10 /share | 22 Sept 2025 | 390.90 | 369.45 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 369.85 | 358.00 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 328.15 | 325.90 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 308.05 | 312.65 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 288.70 | 325.90 |
Gufic BioSciences
392.40
+5.45
(1.41%)
Market Cap
3,935.09 Cr
PE Ratio
60.48
Volume
1,32,576.00
Day High - Low
398.25 - 382.00
52W High-Low
448.00 - 268.00
Key Fundamentals
Market Cap
3,935.09 Cr
EPS
6.40
PE Ratio
60.48
PB Ratio
5.84
Book Value
66.31
EBITDA
151.34
Dividend Yield
0.03 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
11.59
Debt to Equity
0.59
Actual
Company News
View All News
Gufic Biosciences uploads Q1FY27 call audio
Jun 01, 2026
Jun 01, 2026Gufic Biosciences uploaded the audio recording of its Q1FY27 earnings call held on June 01, 2026. The recording is available on the company website.
Gufic Biosciences posts Q4 FY26 resultsMay 30, 2026
May 30, 2026Gufic Biosciences reported Q4 FY26 revenue of ₹252.1 crore and PAT of ₹20.5 crore. The Indore facility achieved 30% capacity utilization.
Gufic Biosciences appoints auditors for FY27May 30, 2026
May 30, 2026Gufic Biosciences re-appointed M/s. Poddar & Co. as Cost Auditor and appointed Mrs. Saroj R. Kirdolia as Internal Auditor for FY27.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,935.50 | #1 4,64,391.28 | 40.42 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 69.33 | |
6,836.00 | 1,81,474.32 | 70.42 | 10,560.00 | 8.73 | 2,520 | 13.44 | 57.88 | |
4,901.50 | 1,65,889.03 | 77.50 | 13,886.20 | 20.34 | 2,138 | -26.91 | 76.03 | |
1,439.40 | 1,16,281.25 | 30.16 | 29,044.60 | 2.24 | 3,870 | -55.32 | 56.29 | |
1,150.80 | 1,15,797.41 | 22.58 | 26,719.70 | 13.65 | 5,242 | 7.82 | 65.75 | |
2,496.30 | 1,14,138.96 | #1 21.37 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 68.54 | |
2,525.10 | 1,04,285.61 | 53.94 | 14,277.60 | 12.03 | 1,750 | 31.75 | 58.02 | |
1,244.30 | 1,03,857.87 | 25.49 | 35,058.60 | 3.90 | 4,158 | -86.05 | 35.49 | |
1,564.70 | 90,029.38 | 26.31 | 33,384.70 | 3.21 | 3,376 | 1.99 | 56.89 | |
1,537.80 | 83,019.15 | 91.21 | 6,867.80 | #1 22.01 | 890 | 21.18 | 64.70 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
14.65 %
Net Income Growth
4.67 %
Cash Flow Change
1,743.03 %
ROE
-28.32 %
ROCE
-16.55 %
EBITDA Margin (Avg.)
-5.77 %
Corporate Action
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.07% | 0 | 0.00% | 0.01% | |
 Bank of India Business Cycle Fund Direct-Growth | 1.29% | 0 | 0.00% | 0.22% | |
Bank of India Manufacturing & Infrastructure Fund Direct-Growth | 0.97% | 0 | 0.00% | 0.13% | |
Bank of India Small Cap Fund Direct-Growth | 0.90% | 0 | 0.00% | 0.08% | |
 ICICI Prudential Bharat Consumption Fund Direct-Growth | 0.00% | 0 | 0.00% | -0.14% | |
ICICI Prudential ELSS Tax Saver Direct Plan-Growth | 0.03% | 0 | 0.00% | 0.00% | |
ICICI Prudential Multicap Fund Direct Plan-Growth | 0.33% | 0 | 0.00% | 0.05% | |
ICICI Prudential Smallcap Fund Direct Plan-Growth | 0.08% | 0 | 0.00% | -0.09% | |
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.01% | 0 | 0.00% | 0.00% | |
Motilal Oswal Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 SBI Healthcare Opportunities Fund Direct Plan-Growth | 0.41% | 0 | 0.00% | 0.04% |
Technical Indicators
RSI(14)
Neutral 60.56
ATR(14)
Less Volatile 19.18
STOCH(9,6)
Neutral 27.35
STOCH RSI(14)
Neutral 25.06
MACD(12,26)
Bearish -1.30
ADX(14)
Strong Trend 43.53
UO(9)
Bearish 38.74
ROC(12)
Uptrend And Accelerating 5.98
WillR(14)
Neutral -59.85
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
